» Articles » PMID: 26131142

Matrine Regulates Immune Functions to Inhibit the Proliferation of Leukemic Cells

Overview
Specialty General Medicine
Date 2015 Jul 2
PMID 26131142
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: To investigate the roles of matrine in regulating immune functions and its effect on the proliferation of leukemic cells.

Methods: Human leukemia K562, OUN-1, HL-60, U937, K562/AO2 cell lines and primary leukemic cells were used to detect the NKG2D ligands (NKG2DL) expression such as MICA/B, ULBP-1, ULBP-2, ULBP-3, and NK cells receptor NKG2D, CD158a, CD158b were detected by flow cytometry. Cell cytotoxic activity of human NK cells and CIK cells against K562 leukemia cells was detected using CFSE/PI double staining. Pro-inflammatory cytokines and adhesion molecules in K562 or NK cells supernatant after matrine treatment were detected.

Results: Matrine could upregulate the expression of NKG2DL on leukemic cell lines, and primary leukemic cells and enhance the NK and CIK cytotoxicity targeted to K562 cells. After matrine treatment, pro-inflammatory cytokines and adhesion molecular such as IL-6, IL-1, IL-2, IL-4, IL-5, GRO and TNF-α in K562 cells supernatant were significantly decreased (P < 0.05). Flow cytometry analysis showed that the NKG2D expression was up-regulated significantly as well as the CD158a and CD158b expression decreased after treatment with different concentration of matrine in a dose-dependent manner in K562 cells. A significant decrease of supernatant concentrations of IL-1α, IL-5, IL-6, IL-10, IFN-γ, GRO and TNF-α in NK cells was also observed after exposure to the matrine.

Conclusion: Matrine regulates immune functions to inhibit the proliferation of leukemic cells.

Citing Articles

Promising Therapeutic Treatments for Cardiac Fibrosis: Herbal Plants and Their Extracts.

Yu X Cardiol Ther. 2023; 12(3):415-443.

PMID: 37247171 PMC: 10423196. DOI: 10.1007/s40119-023-00319-4.


A novel matrine derivative, WM130, inhibits activation and movement of human hepatic stellate LX-2 cells by targeting cofilin 1.

Xu Y, Duan J, Ji W, Liu C, Li X, Wu Q Cytotechnology. 2022; 74(6):613-622.

PMID: 36389285 PMC: 9652194. DOI: 10.1007/s10616-022-00548-w.


Research Advances on Matrine.

Sun X, Jia L, Rong Z, Zhou X, Cao L, Li A Front Chem. 2022; 10:867318.

PMID: 35433636 PMC: 9010661. DOI: 10.3389/fchem.2022.867318.


Matrine exerts antitumor activity in cervical cancer by protective autophagy via the Akt/mTOR pathway and .

Zhang F, Zhang H, Qian W, Xi Y, Chang L, Wu X Oncol Lett. 2022; 23(4):110.

PMID: 35242238 PMC: 8848215. DOI: 10.3892/ol.2022.13230.


A Systematic Review of the Pharmacology, Toxicology and Pharmacokinetics of Matrine.

You L, Yang C, Du Y, Wang W, Sun M, Liu J Front Pharmacol. 2020; 11:01067.

PMID: 33041782 PMC: 7526649. DOI: 10.3389/fphar.2020.01067.


References
1.
Linn Y, Hui K . Cytokine-induced killer cells: NK-like T cells with cytotolytic specificity against leukemia. Leuk Lymphoma. 2003; 44(9):1457-62. DOI: 10.3109/10428190309178764. View

2.
Liu Y, Xu Y, Ji W, Li X, Sun B, Gao Q . Anti-tumor activities of matrine and oxymatrine: literature review. Tumour Biol. 2014; 35(6):5111-9. DOI: 10.1007/s13277-014-1680-z. View

3.
Awad A, Yassine H, Barrier M, Vorng H, Marquillies P, Tsicopoulos A . Natural killer cells induce eosinophil activation and apoptosis. PLoS One. 2014; 9(4):e94492. PMC: 3984162. DOI: 10.1371/journal.pone.0094492. View

4.
Kato N, Tanaka J, Sugita J, Toubai T, Miura Y, Ibata M . Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells. Leukemia. 2007; 21(10):2103-8. DOI: 10.1038/sj.leu.2404862. View

5.
Jiang H, Hou C, Zhang S, Xie H, Zhou W, Jin Q . Matrine upregulates the cell cycle protein E2F-1 and triggers apoptosis via the mitochondrial pathway in K562 cells. Eur J Pharmacol. 2007; 559(2-3):98-108. DOI: 10.1016/j.ejphar.2006.12.017. View